PPD, Inc. (Nasdaq: PPD ) was named one of the “Best Workplaces in Greater China ™ 2021” by Great Place to Work ® for successfully creating an inclusive workplace experience for employees.
PPD, Inc. (Nasdaq: PPD ) was named “Best Vaccine CRO of the Year” at the Asia-Pacific Vaccine Excellence Awards 2021 for its strong presence, extensive experience and quality delivery in the Asia-Pacific...
PPD, Inc. (Nasdaq: PPD ) earned numerous honors at the 2021 PharmaTimes Clinical Researcher of the Year-The Americas competition. Two PPD teams won gold, one team won silver and another team took home...
PPD, Inc. (Nasdaq: PPD ), a leading global contract research organization, today reported its financial results for the third quarter ended September 30, 2021.
Medable Inc. , the leading cloud platform for patient-centered clinical research, today announced $304 million in Series D funding to accelerate global adoption of digital and decentralized clinical trials,...
PPD, Inc. (Nasdaq: PPD ) was named “Clinical Research Company of the Year” at the 2021 PharmaTimes Clinical Researcher of the Year International competition in London.
PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, will host a conference call on Thursday, October 28, 2021, at 8 a.m. (U.S. Eastern Time) to discuss its third quarter 2021 financial...
PPD, Inc. (Nasdaq: PPD ) is the recipient of the 2021 Eagle Award from the Society for Clinical Research Sites (SCRS) for its commitment to advancing clinical research professionalism through strong site...
PPD, Inc. (Nasdaq: PPD ) has been recognized with two global excellence awards for its effective learning programs, honoring the company’s high-performing employee development initiatives supporting...
PPD, Inc. (Nasdaq: PPD ) has been recognized as one of the best in the world for its successful employee learning and development programs by the Association for Talent Development (ATD), a global organization...